IRYCIS
New aptamers for diagnosis of COVID19
Biomarkers / Diagnostic
Autoimmune & Inflammation
Others
Development of therapeutic aptamers against the SARS-Cov2 spike protein and different highly conserved viral peptides in regions involved in the entry of the virus
1R+D